Muckle-Wells Syndrome (MWS)
Also known as: Muckle-wells Syn (MWS) / Muckle-Wells Syndrome / Muckle Wells Syndrome / Cryopyrin-associated periodic syndromes / Familial amyloid nephropathy with urticaria AND deafness (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB06168 | Canakinumab | An interleukin-1β blocker used to treat Periodic Fever Syndromes such as Cryopyrin-Associated Periodic Syndromes (CAPS) and Familial Mediterranean Fever (FMF), and also to treat active Systemic Juvenile Idiopathic Arthritis (SJIA). |
DB06372 | Rilonacept | An IL-1 inhibitor used to treat cryopyrin-associated periodic syndrome, a rare hereditary inflammatory disorder. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB06168 | Canakinumab | Interleukin-1 beta | target |
DB06372 | Rilonacept | Interleukin-1 beta | target |
DB06372 | Rilonacept | Interleukin-1 alpha | target |
DB06372 | Rilonacept | Interleukin-1 receptor antagonist protein | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB06062 | Gevokizumab | 1 / 2 | Withdrawn | 1 |
DB06372 | Rilonacept | 2 | Completed | 1 |
DB06168 | Canakinumab | 3 | Completed | 5 |
DB06372 | Rilonacept | 3 | Completed | 1 |